Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

Clinical trial NCT06876571 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06876571
Sponsor: Invivoscribe, Inc.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

T-Cell Lymphoproliferative Disorder

Start date: 2025-06-02
Primary completion: 2025-11-06
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.